Germany - Healthcare, Regulatory and Reimbursement Landscape

Germany - Healthcare, Regulatory and Reimbursement Landscape

  • June 2021 •
  • 172 pages •
  • Report ID: 6094236 •
  • Format: PDF
Germany - Healthcare, Regulatory and Reimbursement Landscape

The analyst has released its latest report, "Germany - Healthcare, Regulatory and Reimbursement Landscape".The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Germany.

It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure.Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

The German pharmaceutical market is the largest by value and second largest by volume in Europe.Globally, it is the fourth largest market by value after the US, China, and Japan.

The market value, in terms of Euros, increased from €42.1B in 2013 to an estimated €62.4B in 2020 at a Compound Annual Growth Rate (CAGR) of 5.8%. In terms of US dollars, the market increased from $56B in 2013 to an estimated $71.3B in 2020 at a CAGR of 3.7%. The medical devices market of Germany was $21.6B in 2017, which increased at a CAGR of 3% to reach $23.5B in 2020. The market is expected to grow at a CAGR of 4.7% from $26.6B in 2021 to reach $29.6B in 2025.

The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Bayer, Boehringer Ingelheim, GlaxoSmithKline, Merck KGaA, and Pfizer.
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, Alcon, GE Healthcare, Fresenius, and Roche Diagnostics
- An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the German healthcare market

Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the German healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the German healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.